Page last updated: 2024-08-23

paclitaxel and Adenoma, Prostatic

paclitaxel has been researched along with Adenoma, Prostatic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Bhojani, N; Chughtai, B; Elterman, D; Gao, B; Lu, S; Zorn, KC1
Espino, G; Estrella, R; Kaplan, SA; Lay, RR; Pichardo, M; Rijo, E1
Douglas, DA; Gowardhan, B; Leung, HY; Mathers, ME; McCracken, SR; McKie, AB; Robson, CN1
Nightingale, SL1

Reviews

1 review(s) available for paclitaxel and Adenoma, Prostatic

ArticleYear
New Technologies for Treatment of Benign Prostatic Hyperplasia.
    The Urologic clinics of North America, 2022, Volume: 49, Issue:1

    Topics: Ablation Techniques; Alloys; Antineoplastic Agents, Phytogenic; Dilatation; Humans; Male; Minimally Invasive Surgical Procedures; Paclitaxel; Prostatic Hyperplasia; Prostheses and Implants; Robotic Surgical Procedures; Steam; Urinary Catheters

2022

Other Studies

3 other study(ies) available for paclitaxel and Adenoma, Prostatic

ArticleYear
One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia.
    Prostate cancer and prostatic diseases, 2021, Volume: 24, Issue:4

    Topics: Aged; Coated Materials, Biocompatible; Drug Delivery Systems; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Paclitaxel; Prostatic Hyperplasia; Urinary Catheters

2021
Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer.
    British journal of cancer, 2005, Jan-31, Volume: 92, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Synergism; Drug Therapy, Combination; Fibroblast Growth Factors; Humans; Immunohistochemistry; Male; Middle Aged; Paclitaxel; Prostatic Hyperplasia; Prostatic Neoplasms; Recombinant Fusion Proteins; Tumor Cells, Cultured

2005
From the Food and Drug Administration.
    JAMA, 1992, Sep-16, Volume: 268, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Alkaloids; Androstenes; Antineoplastic Agents, Phytogenic; Azasteroids; Female; Finasteride; Humans; Male; Mammaplasty; Neoplasm Metastasis; Ovarian Neoplasms; Paclitaxel; Prostatic Hyperplasia; Prostheses and Implants; Silicones; United States; United States Food and Drug Administration

1992